Live from the NIH registry
Studies recruiting near Birmingham right now
Top 25 of 962 recruiting studies, sorted by proximity — each links to its official registry page
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AB Science
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Flourish - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: AbbVie
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
Excel ENT — Birmingham, Alabama (0.6 mi)
· Sponsor: Airiver Medical, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Veterans Administration Medical Center - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: SWOG Cancer Research Network
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Tufts University
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 260 participants sought
UAB Comprehensive Cancer Center — Birmingham, Alabama (0.6 mi)
· Sponsor: Bristol-Myers Squibb
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Medstar Health Research Institute
Multi-Center Clean Air Randomized Controlled Trial in COPD
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 770 participants sought
University of Alabama, Lung Health Center — Birmingham, Alabama (0.6 mi)
· Sponsor: JHSPH Center for Clinical Trials
Wavelength Intervention for Nearsighted Kids
Myopia
N/A
Interventional 80 participants sought
University of Alabama at Birmingham School of Optometry — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Jaeb Center for Health Research
Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study
Mandibular Surgery
N/A
Interventional 40 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
University of Alabama/Children's of Alabama — Birmingham, Alabama (0.6 mi)
· Sponsor: Giselle Sholler
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: Bayer
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Guardant Health, Inc.
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
AML, ALL
Phase 1
Interventional 50 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Univ of Alabama/Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: Calliditas Therapeutics AB
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
Alzheimer Disease
Phase 2
Interventional 160 participants sought
University of Alabama at Birmingham Medical Center — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Birmingham, Alabama (0.6 mi)
· Sponsor: AstraZeneca
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Cardiology, PC — Birmingham, Alabama (0.6 mi)
· Sponsor: Duke University
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
University of Alabama Hospital — Birmingham, Alabama (0.6 mi)
· Sponsor: Joseph Broderick, MD
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
31788, Alabama CRS — Birmingham, Alabama (0.6 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Brain Uptrain to Improve Learning and Development
Term Infant, Late Preterm Infant
N/A
Interventional 188 participants sought
University of Alabama at Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Preterm Delivery, Obstetrical Complications
Phase 3
Interventional 1,800 participants sought
University of Alabama - Birmingham — Birmingham, Alabama (0.6 mi)
· Sponsor: The George Washington University Biostatistics Center